Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million.
April 29, 2024
Share
Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million on April 24, 2024. The consideration consists of CNY 502.5 million in cash. As part of the consideration, CNY 226 million was paid towards common equity and CNY 276.5 million was paid towards non-convertible debt. Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. reported Total assets worth CNY 832.5 million and Total common equity of CNY 378.5 million as on February 29, 2024.
Transaction was funded by CNY 312.5 million from the Company's own funds and CNY 190 million from part of the excess raised funds. Transaction was already approved by Huaxia Eye Hospital Group's board of director's.
Huaxia Eye Hospital Group Co Ltd is a China-based company mainly engaged in ophthalmic medical business. The Company's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The Company is also engaged in glasses and pharmacy retail business. The Company mainly conducts its business in the domestic market.
HUAXIA EYE HOSPITAL GROUP CO.,LTD. 
